Indraprastha Medical Corporation informs about cessation of executive director & chairman

02 Dec 2023 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with SEBI Circular dated 13thJuly, 2023, Indraprastha Medical Corporation has informed that the Company has received a letter from the Govt. of NCT of Delhi (‘Promoter of the Company’) intimating about withdrawal of nomination of Jasmine Shah from the Board of Directors of the Company, and accordingly, Jasmine Shah has ceased to be the Non-Executive Director & Chairman of the Company. The detailed disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBIVHO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure-A. Further, a copy of aforesaid letter for withdrawal of nomination is also enclosed as Annexure- B.

The above information is a part of company’s filings submitted to BSE.




Indraprastha Medical Share Price

478.10 -11.10 (-2.27%)
23-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7270.35
Max Healthcare Inst 1140.55
Narayana Hrudayalay 1307.35
Aster DM Healthcare 503.45
Global Health 1098.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.